Semax vs. selank: separating peptide hype from actual evidence
Quick answer
Semax and selank are synthetic peptides with Russian pharmacological origins, studied primarily for neurological recovery and anxiety reduction respectively, not for performance optimization in healthy adults. The creator's dosing recommendation of one milligram for both compounds lacks route-of-administration guidance, body weight context, or clinical sourcing, which makes it unsuitable as a practical reference. Neither peptide is FDA-approved, and their safety profiles in healthy populations remain insufficiently characterized in peer-reviewed literature.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @adenpeps actually say?
The creator drew a clean line between two nootropic peptides: semax is for focus and "locking in," and selank is for lowering cortisol, reducing anxiety, and stabilizing mood. They dosed both at one milligram and suggested starting lower. That is essentially the whole argument, delivered with confidence and no citations.
To their credit, they framed the video as "for research purposes only" and not medical advice. That disclaimer does not fully excuse broadcasting specific dosing figures to 8,400 viewers with zero clinical context, but it is worth noting they did not pretend to be a doctor. The framing is still informal enough to carry real risk. Someone anxious, under-informed, and looking for a quick fix will walk away thinking one milligram of selank is just what they need.
Does the science back this up?
Partially, yes. The broad strokes on both peptides are not fabricated. Semax has actual pharmacological research behind it, and selank's anxiolytic properties have been studied in controlled settings. But "partially supported by research" is doing a lot of work here, and the creator's framing is considerably more confident than the evidence warrants.
Semax is a synthetic analog of adrenocorticotropic hormone (ACTH). Russian research, particularly Lebedeva et al. (2008, Experimental and Clinical Pharmacology), identified it as increasing BDNF and improving cognitive performance in stroke recovery patients. That is not the same as making a healthy person "super locked in." The nootropic claims in wellness communities outpace the clinical literature significantly. Selank is a synthetic analog of tuftsin with demonstrated anxiolytic effects. Semenova et al. (2010, CNS Drug Reviews) documented reductions in anxiety and stress markers in both animal and limited human trials. The cortisol claim is plausible but not robustly established in humans at the doses being discussed.
What did they get wrong (or right)?
They got the general character of each peptide directionally right. Semax does appear to support cognitive function. Selank does appear to have anxiolytic properties. The creator deserves credit for not wildly misrepresenting what these compounds are.
What they got wrong: calling semax "a nootropic" without noting it is not approved by the FDA for any use in the United States, and that most available product outside Russia is unregulated and of unknown purity. Describing it as something that can "feel like a stimulant" is also imprecise and potentially misleading. Stimulant and nootropic are not interchangeable mechanisms. More seriously, giving a specific dose of one milligram for both peptides with no body weight guidance, no mention of route of administration, and no discussion of individual variation is irresponsible regardless of the disclaimer. Research on semax typically uses intranasal administration; selank is also commonly intranasal. Neither of those details was mentioned.
What should you actually know?
These are not well-studied compounds in healthy human populations. Most of the clinical research on semax comes from Russian institutions studying neurological recovery patients, not healthy adults trying to study harder. Most selank research is similarly narrow in scope. Extrapolating those findings to general wellness use is a significant leap that the existing literature does not cleanly support.
Neither peptide is FDA-approved. Neither has established dosing standards for healthy adults in peer-reviewed literature. The one milligram figure the creator uses appears to circulate in online peptide communities, not in clinical guidelines. Anyone considering these compounds should have a conversation with a licensed provider who can assess their individual health status, not take dosing cues from a TikTok caption. The peptides may have real mechanisms worth exploring under proper supervision. The way they are being discussed here skips several steps that actually matter.
A note on sourcing
- Semax research base is largely Russian-language and from a narrow patient population (stroke, CNS injury).
- Selank's anxiolytic data is promising but mostly preclinical or small-sample human trials.
- Neither compound has gone through FDA Phase III trials for any indication.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 5 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax vs. selank: separating peptide hype from actual evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
Semax vs. selank: separating peptide hype from actual evidence should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
Compare available products and select the relevant treatment page for its specific next step.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Semax and selank are synthetic peptides with Russian pharmacological origins, studied primarily for neurological recovery and anxiety reduction respectively, not for performance optimization in healthy adults.
FormBlends verdict
Semax and selank are synthetic peptides with Russian pharmacological origins, studied primarily for neurological recovery and anxiety reduction respectively, not for performance optimization in healthy adults. The creator's dosing recommendation of one milligram for both compounds lacks route-of-administration guidance, body weight context, or clinical sourcing, which makes it unsuitable as a practical reference. Neither peptide is FDA-approved, and their safety profiles in healthy populations remain insufficiently characterized in peer-reviewed literature.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax and selank are synthetic peptides with Russian pharmacological origins, studied primarily for neurological recovery and anxiety reduction respectively, not for performance optimization in healthy adults. The creator's dosing recommendation of one milligram for both compounds lacks route-of-administration guidance, body weight context, or clinical sourcing, which makes it unsuitable as a practical reference. Neither peptide is FDA-approved, and their safety profiles in healthy populations remain insufficiently characterized in peer-reviewed literature.
- Semax is a synthetic ACTH analog, not an approved drug in the US; the cognitive enhancement claims are extrapolated from stroke and CNS injury research, not healthy adult trials (Lebedeva et al., 2008).
- Selank showed anxiolytic effects in controlled studies but these were mostly small-sample or animal-based; calling it a mood stabilizer goes beyond what the published evidence supports (Semenova et al., 2010, CNS Drug Reviews).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is a synthetic ACTH analog, not an approved drug in the US; the cognitive enhancement claims are extrapolated from stroke and CNS injury research, not healthy adult trials (Lebedeva et al., 2008).
- Selank showed anxiolytic effects in controlled studies but these were mostly small-sample or animal-based; calling it a mood stabilizer goes beyond what the published evidence supports (Semenova et al., 2010, CNS Drug Reviews).
- Neither semax nor selank has FDA approval for any indication, meaning purity, potency, and safety of commercially available product are not regulated or guaranteed.
- The one milligram dose cited in the video does not come from clinical guidelines; it circulates in online biohacking communities and should not be treated as a safe or validated starting point.
- Route of administration matters significantly for both peptides. Both are typically studied intranasally, a detail the video omits entirely, which changes absorption and effective dose considerably.
- Describing semax as stimulant-like is pharmacologically imprecise; its proposed mechanisms involve BDNF and neuropeptide activity, not dopamine or norepinephrine reuptake inhibition as seen in true stimulants.
- Anyone interested in these compounds should consult a licensed provider who can review their full health history, not rely on social media dosing guidance, regardless of how confident the presenter sounds.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
aden 🦁 · TikTok creator
8.4K views on this video
semax vs selank #bp #fypシ゚viral #ascension #looksmax #clavicular
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by aden 🦁, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.